Riskpilot← Back to searchSign inGet full accessWONDER KLINIKK NORGE AS
ASBankruptOrg 998053900Lilleengveien 8, 1523 MossOther human health activities n.e.c. · NACE 8699Est. 20120 employees
Revenue 2024
NOK 0
EBITDA margin
—
-192% vs 2023
Equity ratio
-15.4%
Financial strength
Net profit 2024
NOK -217K
-216% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -215K | -192% |
| Net profit | NOK -217K | -216% |
| Total assets | NOK 162K | -33% |
| Equity | NOK -25K | -113% |
| Employees | 0 | — |
Legal name
WONDER KLINIKK NORGE AS
Org number
998053900
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
5. mars 2012
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Kroppsforming, behandling med elektromagnetiske bølger og radiofrekvens (rf-behandlling), samt annen virksomhet som naturlig står i forbindelse med dette.
Address
Lilleengveien 8, 1523 Moss
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 2 669 | 0 | 187 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −247 | 2 467 | −25 | 233 | −215 |
| Depreciation & amort. | −164 | −68 | −0 | −0 | −0 |
| EBIT | −411 | 2 398 | −25 | 233 | −215 |
| Net financials | 111 | −40 | −0 | 0 | −3 |
| Profit before tax | −522 | 2 359 | −25 | 233 | −217 |
| Tax | −0 | 89 | −0 | 46 | −0 |
| Net profit | −522 | 2 270 | −25 | 187 | −217 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 370 | 2 768 | 7 | 240 | 162 |
| Equity | −1 925 | 30 | 5 | 192 | −25 |
| Long-term debt | 2 084 | 0 | 0 | 0 | 0 |
| Short-term debt | 3 211 | 2 738 | 2 | 48 | 187 |
| Total debt | 5 295 | 2 738 | 2 | 48 | 187 |
EBITDA margin
-21460700.0%
This company
15.8%
Market median
-135827315% vs market
20202024
Equity ratio
-15.4%
This company
38.2%
Market median
-140% vs market
20202024
Return on equity
-21719200.0%
This company
18.4%
Market median
-118039230% vs market
20202024
Net profit margin
-21719200.0%
This company
8.1%
Market median
-268138372% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
7.50×
This company
0.62×
Market median
-1110% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
ZM Deputy Member | Deputy Member | 2019 |
DM Chief Executive Officer | Chief Executive Officer | 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2019 | |
| Board of Directors | 2019 | |
| Board of Directors | 2019 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of WONDER KLINIKK NORGE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Zlatko Miladin | Deputy Member | 0 companies |
| Dijana Miladin | Chief Executive Officer | 0 companies |
| Gordan Miladin | Chairman | 0 companies |
| Dubravko Miladin | Board of Directors | 0 companies |
| Radmila Miladin | Board of Directors | 0 companies |